JournalArta
Wednesday, November 18, 2026 · JakartaS&P 7,303.98 ▼0.50%USD/IDR 18,249 ▼0.07%
JournalArta
Global Edition
beyond headlines
Advertisement

UK MHRA Launches AdvanceGxP to Speed Up AI and Hospital-Made Medicines

Britain's medicines regulator has opened a new front door for companies building medicine-making technology that does not fit its existing rulebook.

By Alistair Sterling
November 18, 20262 min read
UK MHRA Launches AdvanceGxP to Speed Up AI and Hospital-Made Medicines
UK MHRA Launches AdvanceGxP to Speed Up AI and Hospital-Made Medicines

Britain's medicines regulator has opened a new front door for companies building medicine-making technology that does not fit its existing rulebook. The Medicines and Healthcare products Regulatory Agency (MHRA) launched AdvanceGxP, a service giving developers earlier, practical advice on compliance before they reach the formal approval stage.

The Office for Life Sciences (OLS) is funding the service. Science, Innovation and Investment Minister Chris McDonald announced it in his closing speech at a life sciences gathering in London.

AdvanceGxP is aimed at what the MHRA calls advanced, often disruptive manufacturing methods. That includes personalized treatments produced at or near hospitals and clinics, manufacturing in space, and the use of AI, robotics and automation.

Advertisement

Such methods do not slot neatly into current rules. Developers often run into compliance gaps late, when designs are already fixed and money is spent.

What the service offers

The MHRA says AdvanceGxP will engage developers early to spot potential compliance problems in novel manufacturing workflows. It will also give practical guidance on adapting Good Practice (GxP) standards — the quality and safety rules that govern how medicines are made — to cutting-edge processes.

The agency frames the goal as cutting uncertainty during development and speeding the route to compliance. In its words, the service is meant to accelerate patient access to innovative medicines while strengthening UK manufacturing.

Advertisement

The funding covers development and testing of AdvanceGxP rather than a permanent rollout. Companies and research institutions working on automation, point-of-care production and novel biological processes are the target users.

Why regulators are moving early

Advanced manufacturing is shifting where and how medicines get made. Hospital-based production puts small batches of personalized therapies close to patients; AI and robotics promise faster, more consistent output. Traditional approval pathways were built for large, fixed factories.

The MHRA is also courting overseas developers. Personalized and point-of-care production is a live field in the US and elsewhere, and firms weighing where to pilot new lines now have a named UK entry point for regulatory questions.

Advertisement

The agency has paired the launch with a separate push on women's health. Its new Women's Health Programme targets gaps in evidence on how medicines and devices affect women.

MHRA analysis of 4,616 UK clinical trial applications filed between 2019 and 2023 found pregnant women included in just 1.1% of trials and breastfeeding women in 0.6%. The programme will bring patients, researchers, clinicians and industry together to build that evidence base while keeping safety standards intact.

For now, AdvanceGxP is the concrete next step: developers of AI-driven, robotic or hospital-based manufacturing can approach the MHRA before their processes are locked in.

Advertisement
Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →
Advertisement
Most Read
  1. 1U.S. Emergency Alert Test Nov. 17 Is Not a Power Outage
  2. 2Gold Silver Price November: Futures Rise Near Yearly Lows
  3. 3Michael Clarke Says Sandpapergate Scars Drew Steve Smith to New York
  4. 4GTA 6 New Zealand Time Trick Is Not Guaranteed to Work
  5. 5Sunrise on the Reaping Reviews Split Over Dark Hunger Games Prequel
Advertisement
Don't Miss

Latest News

All stories →
  1. Sport · More SportsUtah Mammoth Unveil Winter Classic Jersey for Outdoor DebutNov 18
  2. Sport · More SportsMariners’ Randy Arozarena Rejects Qualifying Offer, Enters Free AgencyNov 18
  3. Markets · StocksAGL Energy Share Price Rises 0.11% on Wednesday, Near a 3-Month HighNov 18
  4. Lifestyle · EntertainmentFeige Says Marvel Planned Doctor Doom Before Majors ConvictionNov 18
  5. Advertisement
  6. Lifestyle · Food & HealthResearchers Say Most Children Labeled Allergic to Penicillin Are NotNov 18
  7. Lifestyle · Food & HealthAt-Home Microbiome Tests Give Widely Different ResultsNov 18
  8. World · Middle EastIsraeli Tanks Advance Into Central Gaza Beyond Truce LineNov 18
  9. Lifestyle · Food & HealthChina Trial Links Acupuncture Threads to Sustained Weight LossNov 18